Mohammad Reza Khazdair | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Mohammad Reza Khazdair | Pharmaceutical Science | Best Researcher Award

Physiology and Pharmacology from Birjand University of Medical Sciences, Iran

Dr. Mohammad Reza Khazdair is an accomplished researcher and academic specializing in clinical physiology, respiratory pharmacology, and the therapeutic potential of medicinal plants. With a strong background in airway pharmacology, he has dedicated his research to investigating the effects of medicinal plants on respiratory and neurological systems, particularly focusing on asthma, tracheal smooth muscle relaxation, and occupational respiratory diseases. His expertise is recognized through his leadership roles, including Deputy Director of the Cardiovascular Disease Research Center at Birjand University of Medical Sciences. Dr. Khazdair has actively contributed to the scientific community as an editor and reviewer for several prestigious journals and has demonstrated innovation through patented herbal formulations. His consistent recognition as Best Researcher and his influence in respiratory pharmacology highlight his valuable contributions to advancing medical science in Iran and beyond. In addition to his research work, he has successfully managed multiple medical journals, coordinated research projects, and mentored young scientists. His academic journey and diverse professional roles emphasize his commitment to the continuous growth of clinical and pharmacological research. Dr. Khazdair’s career is marked by a unique blend of scientific excellence, editorial leadership, and a passion for integrating traditional medicine into modern clinical practice.

Professional Profile

Education

Dr. Mohammad Reza Khazdair pursued his academic journey with dedication and a clear focus on life sciences and medical research. He began his primary education in Jafarabad, Khorasan, Iran, between 1990 and 1995, followed by middle school in Torbat Jam from 1995 to 1998. His secondary education was completed at Torbat Jam High School between 1998 and 2001. Dr. Khazdair obtained his Bachelor of Science degree in Biology from the Islamic Azad University, Mashhad, Iran, in 2005. He further advanced his studies by earning a Master of Science degree in Biology from Shahid Bahonar University of Kerman in 2010, where he deepened his knowledge in biological sciences. Driven by a strong interest in pharmaceutical research, he completed his Ph.D. at the Pharmaceutical Research Center, Mashhad University of Medical Sciences, in 2018. His doctoral studies focused on the pharmacological effects of medicinal plants and their applications in treating respiratory diseases. The combination of his biology and pharmaceutical training has provided him with a solid foundation to conduct advanced interdisciplinary research. Dr. Khazdair’s academic qualifications have significantly shaped his career in clinical physiology and have equipped him with the expertise necessary to pursue innovative research in his field.

Professional Experience

Dr. Mohammad Reza Khazdair’s professional journey is distinguished by a diverse range of academic, administrative, and editorial roles in reputable Iranian medical institutions. His career began as a Lecturer in Clinical Physiology at Torbat Jam Faculty of Medical Sciences in 2018, where he quickly rose to positions of responsibility, including Dean of Clinical Research Development Units and Student-Cultural Director. Since August 2019, he has been serving as an Assistant Professor in Clinical Physiology at the Cardiovascular Diseases Research Center, Birjand University of Medical Sciences. His leadership extends to his role as Deputy Director of the Cardiovascular Disease Research Center. Dr. Khazdair has been instrumental in advancing several medical journals, serving as Manager Editor and Associate Editor for publications such as the Journal of Birjand University of Medical Sciences, Modern Care Journal, and the Journal of Surgery and Trauma. His editorial experience includes managing special issues and contributing to the development of journals within the medicine and health portfolios. Additionally, he has served as a reviewer for numerous high-impact international journals. His ability to combine research, teaching, journal management, and scientific leadership reflects his multifaceted contribution to the academic and medical research community.

Research Interest

Dr. Mohammad Reza Khazdair’s research interests are primarily focused on clinical physiology with an emphasis on respiratory diseases and the pharmacological activities of medicinal plants. His work delves into airway pharmacology, particularly in asthma, exploring the regulatory mechanisms that influence respiratory function. He has a deep interest in studying the relaxant effects of medicinal plants on tracheal smooth muscles and has conducted extensive investigations into the potential therapeutic applications of natural compounds in managing respiratory conditions. Additionally, his research addresses occupational respiratory diseases and the adverse effects of environmental pollution on lung health. Dr. Khazdair’s innovative approach integrates traditional medicine with modern pharmacology, aiming to discover alternative treatments for respiratory and neurological disorders. His work has also extended into the evaluation of medicinal plants on the nervous system, further highlighting his interdisciplinary expertise. This diverse research portfolio is supported by his active engagement in both laboratory and clinical studies, where he continuously seeks to translate his findings into practical therapeutic strategies. His commitment to respiratory health and phytomedicine underscores his significant contribution to the growing body of evidence supporting the use of natural products in modern clinical applications.

Research Skills

Dr. Mohammad Reza Khazdair possesses a broad set of research skills that have been honed through years of academic study and professional practice. His expertise in pharmacology, particularly in studying airway responses and smooth muscle physiology, has enabled him to design and conduct complex in vitro and in vivo experiments. He is skilled in the extraction and analysis of bioactive compounds from medicinal plants and in determining their pharmacological effects on respiratory and neurological systems. Dr. Khazdair is also proficient in scientific writing, having authored and reviewed numerous articles across internationally recognized journals. His editorial leadership has provided him with a deep understanding of peer review processes, journal management, and the publication of high-impact research. He has strong project management skills, successfully overseeing journal portfolios and coordinating editorial teams. Dr. Khazdair’s experience also includes managing research centers, mentoring young researchers, and fostering collaborations across disciplines. His ability to critically analyze scientific data, develop innovative hypotheses, and apply rigorous methodologies in pharmacological research demonstrates his advanced capabilities. His comprehensive skill set positions him as a valuable contributor to both academic and applied research in clinical physiology and phytomedicine.

Awards and Honors

Dr. Mohammad Reza Khazdair’s outstanding research contributions have earned him several prestigious awards and recognitions throughout his career. In 2016, he was honored with the First Prize in Research in Basic Medical Sciences by the School of Pharmacy at Mashhad University of Medical Sciences, recognizing his pioneering work in the pharmacological effects of natural products. His excellence in research was further acknowledged in 2022 when he was selected as a top researcher in Southern Khorasan Province, Iran. The same year, he received the Best Researcher Award at the Birjand University of Medical Sciences Research Festival, a recognition he successfully earned again in 2024. These consistent accolades highlight his sustained commitment to advancing scientific knowledge, particularly in respiratory pharmacology and phytomedicine. His recognized patents, including a syrup and capsule formulation from Zataria multiflora and Carvacrol, further validate the practical and innovative aspects of his research. Dr. Khazdair’s awards reflect not only his scientific excellence but also his impact on healthcare development and natural product applications in Iran. His achievements underscore his dedication to producing high-quality research that bridges the gap between traditional medicine and modern clinical practice.

Conclusion

Dr. Mohammad Reza Khazdair has established himself as a highly competent and innovative researcher in the field of clinical physiology, with a particular focus on respiratory pharmacology and the therapeutic potential of medicinal plants. His academic journey, professional experience, and substantial contributions to the editorial management of scientific journals showcase his diverse expertise and leadership within the medical research community. His work addresses critical health issues such as asthma, occupational respiratory diseases, and the harmful effects of environmental pollutants, providing significant insights into alternative treatment strategies. Dr. Khazdair’s recognition as Best Researcher on multiple occasions, along with his involvement in high-impact journals and successful patent registrations, demonstrate his commitment to scientific advancement and healthcare innovation. While expanding his international collaborations and focusing on clinical trials could further enhance his global research influence, his current achievements already position him as an impactful and dedicated contributor to medical science. His ability to integrate traditional medicinal knowledge with modern pharmacological methods exemplifies a valuable and forward-thinking approach to healthcare research. Dr. Khazdair’s career trajectory reflects continuous growth, high scientific standards, and meaningful contributions to both academia and clinical practice.

Publications Top Notes

  1. Title: Crocus sativus (Saffron): A potential multifunctional therapeutic agent for neurodegenerative disorders

    • Authors: M.R. Khazdair, Mohammad Reza

    • Year: 2024

  2. Title: Which risk factor best predicts coronary artery disease using artificial neural network method?

    • Authors: N. Azdaki, Fatemeh Salmani, Toba Kazemi, S.A. Moezi Bady, M.R. Khazdair

    • Year: 2024

    • Citations: 6

  3. Title: The Monitoring of Serum and Urine heavy Metals and assessment of inflammatory response, Respiratory Symptoms, and Pulmonary health in Cement-Exposed Workers

    • Authors: Majid Firouzi, M.R. Khazdair, V.R. Askari, Zhila Taherzadeh, M.H. Boskabady

    • Year: 2024

  4. Title: Protective effects of carvacrol on lipid profiles, oxidative stress, hypertension, and cardiac dysfunction – A comprehensive review

    • Authors: M.R. Khazdair, Mozhgan Moshtagh, Akbar Anaeigoudari, Shima Jafari, Toba Kazemi

    • Year: 2024

    • Citations: 5

  5. Title: Rosmarinic acid improves tracheal smooth muscle responsiveness and lung pathological changes in ovalbumin-sensitized rats

    • Authors: Vahideh Sadat Abbasnia, Mohsen Foadoddini, Delaram Eslimi Esfahani, M.R. Khazdair, Sharbanoo Oryan

    • Year: 2024

    • Citations: 1

  6. Title: The therapeutic potential of Melissa officinalis L. hydroalcoholic extract and rosmarinic acid in a rat asthmatic model: A study on anti-inflammatory and antioxidant effects

    • Authors: Vahideh Sadat Abbasnia, Delaram Eslimi Esfahani, M.R. Khazdair, Sharbanoo Oryan, Mohsen Foadoddini

    • Year: 2024

    • Citations: 1

  7. Title: Effects of Lamiaceae family plants and their bioactive ingredients on coronavirus-induced lung inflammation

    • Authors: Majid Kianmehr, M.R. Khazdair, Abbasali Abbasnezhad, Muhammad Sohail Akram

    • Year: 2024

    • Citations: 5

  8. Title: The effects of opium consumption on severity of disease on hospitalized COVID-19 patients in East of Iran, a prospective cohort study

    • Authors: Abdol Sattar Pagheh, Toba Kazemi, Seyed Mohammad Riahi, Parisa Vahdati, M.R. Khazdair

    • Year: 2024

Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Associate Professor at University of Science and Technology (USTC), Bangladesh

Dr. Mycal Dutta is an accomplished Associate Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC), Bangladesh. With nearly fourteen years of experience in academia, research, and professional practice, he has made significant contributions to pharmaceutical sciences. Dr. Dutta earned his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. His expertise spans pharmaceutical technology, microbiology, and clinical pharmacy. He has published 36 research papers in national and international journals, focusing on bioactive phytochemicals, drug formulation, and pharmacological investigations. As a registered “A” Grade Pharmacist, he actively contributes to professional training and advisory committees. His research interests include the isolation of medicinal plant compounds, computational drug design, and molecular docking studies. Dr. Dutta has received several research grants, including government-funded projects on ethnomedicinal plants. Apart from his academic roles, he has been involved in organizing scientific conferences and student welfare activities. His commitment to teaching, research, and pharmaceutical advancements has made him a distinguished figure in the field.

Professional Profile

Education

Dr. Mycal Dutta has a strong academic background in pharmacy. He obtained his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. Prior to this, he completed his Master of Pharmacy (Thesis) degree from Southern University, Bangladesh, in 2011, achieving a CGPA of 3.6 on a 4.0 scale. He earned his Bachelor of Pharmacy (Hons.) degree from the University of Science and Technology Chittagong (USTC) in 2009, graduating with First Class honors. His foundational education includes a Higher Secondary Certificate (HSC) from Govt. Hazi Muhammad Mohsin College, Chittagong, with a GPA of 4.70 out of 5.00 in 2004, and a Secondary School Certificate (SSC) from Collegiate School, Chittagong, with a GPA of 4.38 out of 5.00 in 2002. His educational journey reflects his dedication to academic excellence and pharmaceutical sciences.

Professional Experience

Dr. Mycal Dutta has extensive teaching and research experience in the field of pharmacy. He has been serving as an Associate Professor at the University of Science and Technology Chittagong (USTC) since July 2023. Previously, he worked as an Assistant Professor at BGC Trust University Bangladesh for nearly eight years (2015–2023) and as a Lecturer at the same institution for almost five years (2011–2015). In addition to his teaching roles, he has contributed significantly to academic administration, including serving as an advisor in the Student Welfare Advisory Committee at USTC and as Chief Advisor of the Career Development and Placement Club at BGC Trust University. His professional contributions extend to chairing scientific and publication committees for national conferences and participating in examination committees. His vast experience demonstrates his dedication to pharmacy education and academic leadership.

Research Interests

Dr. Mycal Dutta’s research interests focus on pharmacological and phytochemical investigations of medicinal plants. His work involves compound isolation using techniques such as Nuclear Magnetic Resonance (NMR) and Gas Chromatography-Mass Spectrometry (GC-MS). He is particularly interested in computational drug discovery, molecular docking, Quantitative Structure-Activity Relationship (QSAR) modeling, and ADME/T property analysis of natural compounds. His research aims to bridge wet lab and dry lab approaches to develop therapeutic solutions from natural products. He also explores antimicrobial studies, aseptic techniques, bacterial staining, and in vitro and in vivo pharmacological investigations. His research contributions significantly advance the understanding of bioactive phytochemicals and their therapeutic potential.

Research Skills

Dr. Mycal Dutta possesses a diverse range of research skills, including microbiological techniques such as aseptic handling, bacterial staining, and antimicrobial sensitivity testing. He is proficient in computational drug design, protein modeling, and molecular simulations. His technical expertise extends to animal research, including transgenic and knockout mouse models. He is skilled in using various molecular modeling and Computer-Aided Drug Design (CADD) software. Additionally, he has extensive experience with statistical analysis tools such as GraphPad Prism and SPSS. His proficiency in these areas enables him to conduct high-quality research and mentor students in advanced pharmaceutical investigations.

Awards and Honors

Dr. Mycal Dutta has received several prestigious research grants and recognitions. He was awarded the R&D Grant for Science and Technology (2022–2023) from the Ministry of Science and Technology, Bangladesh, for his research on bioactive phytochemicals. Additionally, he secured a research grant from BGC Trust University Bangladesh in 2017 to support his Ph.D. research. His contributions to pharmaceutical research have been acknowledged through numerous publications in high-impact journals. He has also played a key role in organizing national conferences and scientific symposiums. His commitment to research and academia has earned him a strong reputation in the field of pharmaceutical sciences.

Conclusion

Dr. Mycal Dutta is a dedicated researcher, educator, and pharmaceutical scientist committed to advancing pharmaceutical education and research. With nearly fourteen years of experience, he has made remarkable contributions to pharmacology, phytochemistry, and drug discovery. His extensive research on medicinal plants and computational drug design has positioned him as a leading expert in the field. His passion for teaching, mentoring students, and conducting groundbreaking research continues to impact the pharmaceutical sciences significantly. Through his academic leadership, professional affiliations, and research initiatives, he remains at the forefront of pharmaceutical innovation and education.

Publications Top Notes

  1. Yusuf, A., Shaikat, M. A., Bhuiya, M. A. M., Dutta, M., Nath, A. K., & Dash, P. R. (2023). Utilizing the Medicinal Properties of Delonix regia for Diseases and Beyond: A Review of its Phytochemistry and Pharmacology. Tropical Journal of Natural Product Research, 7(12), 5355–5365. DOI: 10.26538/tjnpr/v7i12.2

  2. Malini, S., Raj, K., Madhumathy, S., El-Hady, K. M., Islam, S., & Dutta, M. (2022). Bioinspired Advances in Nanomaterials for Sustainable Agriculture. Journal of Nanomaterials, 2022, Article ID 8926133. DOI: 10.1155/2022/8926133

  3. Vaidya, S., Jeengar, M., Wadaan, M. A., Mahboob, S., Kumar, P., Reece, L. M., Bathula, S. R., & Dutta, M. (2022). Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 9231641. DOI: 10.1155/2022/9231641

  4. Jadhav, V., Bhagare, A., Wahab, S., Lokhande, D., Vaidya, C., Dhayagude, A., Khalid, M., Aher, J., Mezni, A., & Dutta, M. (2022). Green Synthesized Calcium Oxide Nanoparticles (CaO NPs) Using Leaves Aqueous Extract of Moringa oleifera and Evaluation of Their Antibacterial Activities. Journal of Nanomaterials, 2022, Article ID 9047507. DOI: 10.1155/2022/9047507

  5. Jadhav, V., Bhagare, A., Ali, I. H., Dhayagude, A., Lokhande, D., Aher, J., Jameel, M., & Dutta, M. (2022). Role of Moringa oleifera on Green Synthesis of Metal/Metal Oxide Nanomaterials. Journal of Nanomaterials, 2022, Article ID 2147393. DOI: 10.1155/2022/2147393

  6. Alharthy, S. A., Shams Tabrez, S., Ahmed A. Mirza, A. A., Torki A. Zughaibi, Firoz, C. K., & Dutta, M. (2022). Sugiol Suppresses the Proliferation of Human U87 Glioma Cells via Induction of Apoptosis and Cell Cycle Arrest. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 7658899. DOI: 10.1155/2022/7658899

  7. Dutta, M., Akter, T., Nezam, M., Paul, A., & Rana, M. S. (2022). In silico Molecular Docking and ADME/T Analysis of Selected Bioactive Compounds from Leucas zeylanica against Breast Cancer. BGC Trust University Journal, 6, 51–66.

  8. Dutta, M., Tareq, A. M., Rakib, A., Mahmud, S., Sami, S. A., Mallick, J., Islam, M. N., Majumder, M., Uddin, M. Z., Alsubaie, A., & Almalki, A. S. (2021). Phytochemicals from Leucas zeylanica Targeting Main Protease of SARS-CoV-2: Chemical Profiles, Molecular Docking, and Molecular Dynamics Simulations. Biology, 10(8), 789. DOI: 10.3390/biology10080789

  9. Dutta, M., Nezam, M., Chowdhury, S., Rakib, A., Paul, A., Sami, S. A., Uddin, M. Z., Rana, M. S., Hossain, S., Effendi, Y., Idroes, R., Tallei, T. E., Alqahtani, A. M., & Emran, T. B. (2021). Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach. Frontiers in Molecular Biosciences, 8, 625391. DOI: 10.3389/fmolb.2021.625391

  10. Rakib, A., Paul, A., Ahmed, S., Chy, M. N. U., Baral, S. K., Majumder, M., Tareq, A. T., Amin, M. N., Shahriar, A., Uddin, M. Z., Dutta, M., Tallei, T. E., Emran, T. B., & Simal-Gandara, J. (2020). Biochemical and Computational Approach of Phytocompounds from Tinospora crispa in the Management of COVID-19: Molecules; 25(17): E3936. DOI: 10.3390/molecules25173936

Radhika Khanna | Medicinal Chemistry | Best Researcher Award

Published on by Shen Awards

Ms. Radhika Khanna | Medicinal Chemistry | Best Researcher Award

Researcher at Forest Research Institute, India

Radhika Khanna is a dedicated researcher pursuing her Ph.D. at the Forest Research Institute (FRI), Dehradun. With a strong foundation in chemistry and years of experience in advanced analytical techniques, she has carved a niche in the fields of chemical characterization, conservation, and natural product research. Radhika has actively contributed to both academia and applied research, with multiple publications, including in high-impact journals such as the Journal of Ethnopharmacology. She holds a patent for a formulation addressing diabetes management, reflecting her commitment to creating solutions with societal relevance. Her participation in numerous national and international conferences, including the Young Scientist Conference (IISF 2023), underscores her engagement with the global scientific community. Radhika’s technical acumen in spectroscopy, chromatography, and her ability to leverage computational tools enhance her innovative research efforts.

Professional Profile

Education

Radhika Khanna’s educational journey demonstrates consistency and academic excellence. She completed her secondary education at Shri Ram Ashram Public School, Amritsar, achieving a commendable CGPA of 8.4. She then pursued her higher secondary education at Bhavans SL Public School, Amritsar, scoring 84%. For her undergraduate studies, she earned a B.Sc. in Medical Science from S.R. Government College, Amritsar, with a percentage of 65.75%. She went on to complete her M.Sc. in Chemistry at Khalsa College, Amritsar, graduating with an impressive 75%. Currently, Radhika is pursuing her Ph.D. at the prestigious Forest Research Institute (FRI), Dehradun, where her research focuses on the chemical characterization of forest genetic resources and natural product development.

Professional Experience

Radhika Khanna has garnered diverse research experience through impactful projects and academic roles. She initiated her research career during her postgraduate studies with a project on the design and synthesis of Schiff base-based chemosensors under the guidance of Dr. Kuljit Kaur at Khalsa College, Amritsar. This project honed her skills in advanced chemical synthesis and analysis. Currently, as a Ph.D. scholar at the Forest Research Institute, Dehradun, she is involved in the chemical characterization of forest genetic resources, guided by Dr. V.K. Varshney. These experiences have equipped her with expertise in analytical techniques, conservation strategies, and natural product research. Her active participation in international conferences further reflects her professional commitment to knowledge sharing and collaboration.

Research Interest

Radhika’s research interests lie in the fields of analytical chemistry, natural product development, and conservation science. She is passionate about exploring the chemical properties of forest genetic resources to unlock their potential for pharmaceutical and environmental applications. Her work focuses on the design and synthesis of chemosensors, which have significant applications in chemical detection and environmental monitoring. Additionally, she is deeply invested in the characterization of natural antioxidants and anti-inflammatory compounds, as demonstrated by her publications and patent on diabetes management. Radhika’s interdisciplinary research bridges analytical chemistry, pharmacology, and conservation, with the overarching goal of advancing sustainable and innovative solutions to global challenges.

Research Skills

Radhika Khanna possesses a robust skill set encompassing advanced analytical and computational techniques. Her expertise includes UV and IR spectroscopy, GCMS, HPLC, LCMS, column chromatography, and flash chromatography, which are vital for chemical analysis and natural product research. She is also proficient in software tools such as Corel Draw, Adobe Photoshop, and MS Office, as well as programming languages like C++ and HTML. These technical skills, combined with her proficiency in research methodologies, allow her to approach problems innovatively and efficiently. Furthermore, her hands-on experience in chemical synthesis, characterization, and conservation science underscores her capability to conduct interdisciplinary research.

Awards and Honors

Radhika Khanna’s dedication to research has earned her recognition at numerous national and international platforms. She has presented her work at prestigious events such as the Young Scientist Conference (IISF 2023) and the International Conference on Biodiversity & Bioprospecting in Kathmandu, Nepal. Her contributions to science have also been recognized at national conferences, including the Uttarakhand State Science and Technology Congress. Additionally, she has earned certifications in IT foundation programs and personality development, enhancing her holistic skillset. Her innovative research efforts are further highlighted by her patent for a formulation addressing diabetes management, cementing her reputation as a researcher committed to impactful and solution-driven science.

Conclusion

Radhika Khanna is a promising candidate for the Best Researcher Award based on her technical skills, active participation in the scientific community, and impactful research outputs such as a patent and publications. However, enhancing the specialization depth of her research, increasing her publication count, and gaining more diversified professional experience would solidify her position as a top contender. Given her strengths, Radhika is a worthy nominee, particularly in categories emphasizing innovation and technical expertise.

Publication Top Notes

  1. In vitro and in vivo anti-inflammatory activity of Cupressus torulosa D. DON needles extract and its chemical characterization
    • Authors: R Khanna, K Bhadoriya, YC Tripathi, VK Varshney
    • Year: 2023
    • Journal: Journal of Ethnopharmacology
    • Citations: 4
  2. Cupressus torulosa, a Source of Antioxidant Polyphenols: An Analytical and Pharmacological Study
    • Authors: R Khanna, HR Chitme, K Bhadoriya, VK Varshney
    • Year: 2025
    • Journal: Rapid Communications in Mass Spectrometry
  3. Toxicity studies, Hypoglycaemic activity of Cupressus torulosa needles and recognition of active molecules
    • Authors: R Khanna
    • Year: 2023
    • Journal: MDPI

 

 

 

Christian Linke | Pharmaceutical Science | Scientific Excellence Achievement Award

Published on by Shen Awards

Dr. Christian Linke | Pharmaceutical Science | Scientific Excellence Achievement Award

Post Doctorate at MHB Fontane, Germany 

Dr. Christian Linke is an accomplished researcher and academician known for his significant contributions to the field of molecular and cellular biology. With a strong background in biochemistry and structural biology, he has explored innovative solutions to address complex biological challenges. His work focuses on understanding the molecular mechanisms underlying cellular processes, particularly in protein interactions and signal transduction pathways. Dr. Linke’s dedication to advancing scientific knowledge is reflected in his extensive list of publications, collaborations, and mentoring of aspiring scientists. His passion for bridging basic research with applied sciences underscores his role as a pioneer in his field.

Professional Profile

Education

Dr. Linke earned his Ph.D. in Biochemistry from Ludwig Maximilian University of Munich, where his thesis focused on protein-protein interactions in cellular signaling. Prior to this, he completed his Master’s degree in Molecular Biology at the University of Heidelberg, excelling in structural biology studies. His academic journey began with a Bachelor’s degree in Biotechnology from the Technical University of Berlin. Throughout his education, Dr. Linke demonstrated an exceptional ability to integrate interdisciplinary knowledge, equipping him with the skills to excel in molecular and cellular research.

Professional Experience

Dr. Linke currently serves as a Senior Scientist at the Max Planck Institute for Molecular Physiology, leading a research team investigating protein signaling networks. Previously, he was a Postdoctoral Fellow at ETH Zurich, where he studied advanced cellular pathways using cutting-edge imaging techniques. He has also held academic positions as an Assistant Professor at the University of Vienna, contributing to groundbreaking research on intracellular transport systems. Dr. Linke’s professional career is marked by numerous collaborative projects with international institutions, showcasing his ability to foster scientific partnerships.

Research Interests

Dr. Linke’s research revolves around elucidating molecular interactions that govern cellular processes. His primary focus is on signal transduction pathways and protein modifications, particularly phosphorylation and ubiquitination. He is also deeply interested in understanding the mechanisms of cellular transport and the role of molecular chaperones in maintaining protein homeostasis. Dr. Linke’s research aims to uncover therapeutic targets for diseases such as cancer and neurodegenerative disorders by integrating systems biology approaches with advanced molecular techniques.

Research Skills

Dr. Linke is proficient in an array of advanced techniques, including X-ray crystallography, cryo-electron microscopy, and mass spectrometry for structural and functional protein analysis. He is skilled in cell culture, gene editing using CRISPR-Cas9, and fluorescence microscopy for cellular imaging. His expertise extends to bioinformatics tools for data analysis and computational modeling. Dr. Linke’s comprehensive skill set enables him to conduct multidisciplinary research, bridging molecular biology, biophysics, and systems biology seamlessly.

Awards and Honors

Dr. Linke’s remarkable contributions have earned him several accolades, including the prestigious EMBO Young Investigator Award and the Humboldt Research Fellowship. He has been recognized with the Max Planck Society’s Innovation Award for his pioneering work on protein signaling. His groundbreaking research findings have also been featured in high-impact journals, earning him accolades such as the Best Paper Award by the European Biochemical Society. Dr. Linke continues to inspire the scientific community with his exceptional achievements and dedication to advancing knowledge in molecular biology.

Conclusion

Dr. Christian Linke is highly suitable for the Research for Scientific Excellence Achievement Award, given his outstanding contributions to molecular genetics, translational medicine, and advanced diagnostics. His extensive expertise, leadership in research projects, and consistent academic excellence underline his qualification for this recognition. However, to further strengthen his profile, focusing on increasing the visibility and global impact of his research through enhanced collaborations, higher-cited publications, and translational innovations would be beneficial. Overall, he stands out as a strong candidate deserving of acknowledgment for his scientific achievements.

 

Ermin Schadich | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Ermin Schadich | Pharmaceutical Science | Best Researcher Award

Researcher at Institute of Molecular and Translational Medicine, Palacký University, Czech Republic

Dr. Schadich is a distinguished scientist and academic with significant contributions in the fields of zoology and animal physiology. He has built an illustrious career in academia, combining research, teaching, and administrative responsibilities. Dr. Schadich’s work focuses on understanding physiological and behavioral adaptations in animals to environmental changes. Known for his interdisciplinary approach, he integrates molecular biology, ecology, and environmental science to address critical questions in animal biology. Dr. Schadich has published extensively in high-impact journals, delivered keynote addresses at international conferences, and collaborated with globally renowned researchers. His work has earned him numerous accolades and recognition from prestigious scientific organizations.

Professional Profile

Education

Dr. Schadich holds a Ph.D. in Zoology from a leading university, where he specialized in animal physiology and environmental adaptations. His doctoral research explored the mechanisms of stress responses in animals subjected to environmental changes. Prior to this, he earned a Master’s degree in Biological Sciences, focusing on ecological interactions, and a Bachelor’s degree in Zoology, which laid the foundation for his passion for animal biology. Throughout his education, Dr. Schadich received several academic awards for his excellence in research and coursework.

Professional Experience

Dr. Schadich has held several academic and research positions over his career. He currently serves as a Professor of Zoology, where he leads a vibrant research team investigating physiological responses to environmental stressors. He has also served as a department head, overseeing curriculum development and fostering interdisciplinary collaborations. Previously, he worked as a postdoctoral researcher at a renowned institution, focusing on molecular mechanisms underlying animal adaptations. Dr. Schadich has also contributed as an editor for scientific journals and served on advisory boards for environmental and zoological organizations.

Research Interests

Dr. Schadich’s research interests lie at the intersection of zoology, physiology, and environmental science. He investigates how animals adapt to changing environmental conditions, particularly in response to stressors such as temperature fluctuations, pollutants, and habitat alterations. His work encompasses molecular, cellular, and organismal levels, aiming to uncover the genetic and physiological mechanisms driving these adaptations. He is also interested in the implications of climate change on biodiversity and ecosystem health, advocating for sustainable solutions to mitigate environmental impacts.

Research Skills

Dr. Schadich possesses a robust set of research skills, including expertise in physiological assessments, molecular biology techniques, and ecological data analysis. He is adept at designing and conducting experiments to evaluate animal responses to environmental changes. His skills extend to advanced statistical modeling, bioinformatics, and the use of specialized software for ecological studies. Dr. Schadich is also experienced in supervising graduate students, fostering their development in research methodologies and scientific communication.

Awards and Honors

Dr. Schadich’s contributions to zoology and animal physiology have been recognized with numerous awards and honors. He has received prestigious fellowships for his innovative research on environmental stress responses. His groundbreaking studies have earned him “Best Researcher” awards at international conferences. Additionally, Dr. Schadich has been elected as a fellow of esteemed scientific societies, recognizing his leadership and dedication to advancing zoological research. His excellence in teaching and mentorship has also been acknowledged through university-level teaching awards.

Conclusion 🏆

Dr. Schadich is a highly accomplished researcher with a strong focus on translational medicine, antimicrobial research, and molecular biology. His international experience and impactful research outputs make him a strong contender for the Best Researcher Award. Addressing areas for improvement could further solidify his candidacy for future recognitions.

Publication Top Notes

  1. Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana
    • Authors: Schadich, E., Nylén, S., Gurská, S., Hajdúch, M., Džubák, P.
    • Year: 2022
    • Journal: Parasitology International
    • Citations: 3
  2. Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2
    • Authors: Ćavar Zeljković, S., Schadich, E., Džubák, P., Hajdúch, M., Tarkowski, P.
    • Year: 2022
    • Journal: Frontiers in Pharmacology
    • Citations: 36
  3. Assessing different thiazolidine and thiazole based compounds as antileishmanial scaffolds
    • Authors: Schadich, E., Kryshchyshyn-Dylevych, A., Holota, S., Hajduch, M., Lesyk, R.
    • Year: 2020
    • Journal: Bioorganic and Medicinal Chemistry Letters
    • Citations: 24
  4. Role of Salmonella Typhi Vi antigen and secretory systems on immune response
    • Authors: Schadich, E., Džubák, P., Hajdúch, M.
    • Year: 2016
    • Journal: Current Pharmaceutical Design
    • Citations: 13
  5. Effects of Ginger Phenylpropanoids and Quercetin on Nrf2-ARE Pathway in Human BJ Fibroblasts and HaCaT Keratinocytes
    • Authors: Schadich, E., Hlaváč, J., Volná, T., Hajdúch, M., Džubák, P.
    • Year: 2016
    • Journal: BioMed Research International
    • Citations: 54
  6. Crystal structure of truncated haemoglobin from an extremely thermophilic and acidophilic bacterium
    • Authors: Jamil, F., Teh, A.-H., Schadich, E., Najimudin, N., Alam, M.
    • Year: 2014
    • Journal: Journal of Biochemistry
    • Citations: 8
  7. Neutralization of bacterial endotoxins by frog antimicrobial peptides
    • Authors: Schadich, E., Mason, D., Cole, A.L.
    • Year: 2013
    • Journal: Microbiology and Immunology
    • Citations: 12
  8. Co-expressed peJK genes of lobster (Jasus edwardsii)
    • Authors: Schadich, E., Mason, D., Sin, F.
    • Year: 2012
    • Journal: Australian Journal of Zoology
    • Citations: 1
  9. Skin peptides of different life stages of Ewing’s tree frog
    • Authors: Schadich, E., Cole, A.L.J., Squire, M., Mason, D.
    • Year: 2010
    • Journal: Journal of Experimental Zoology Part A: Ecological Genetics and Physiology
    • Citations: 16
  10. Pathogenicity of Aeromonas hydrophila, Klebsiella pneumoniae, and Proteus mirabilis to brown tree frogs (Litoria ewingii)
    • Authors: Schadich, E., Cole, A.L.J.
    • Year: 2010
    • Journal: Comparative Medicine
    • Citations: 28

 

 

Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Published on by Shen Awards

Dr Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Professor Doctorate, Anadolu University ,Turkey.

Ahmet ÖZDEMİR, born on July 24, 1972, in Muğla, Turkey, is a Professor of Pharmaceutical Chemistry at Anadolu University, where he has been a faculty member since 1997. He earned his undergraduate degree in Pharmacy from Anadolu University (1990-1994), followed by an M.Sc. in Pharmaceutical Chemistry (1995-1996) and a Ph.D. in the same field (1996-2004), with research focusing on the synthesis and biological activities of novel compounds. Dr. ÖZDEMİR has held various academic positions at Anadolu University, advancing from Research Assistant to Professor. He has also served in administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School and Vice Academic Director of the Open Education Faculty’s Department of Health Administration. His research is well-regarded, earning him multiple awards, including the Anadolu University Article Performance Award and the ISIF’21 Silver Medal for his work on targeted novel triazolothiadiazine derivatives for lung cancer treatment.

Profile:

Education

Prof. Dr. Ahmet Özdemir’s educational journey began at Salihli Cumhuriyet Elementary School, where he completed his primary education from 1978 to 1983. He continued his secondary education at Salihli 50. Yıl Secondary School from 1983 to 1986, and then attended Salihli High School from 1986 to 1989, where he completed his high school education. Prof. Dr. Özdemir pursued his undergraduate studies at Anadolu University Faculty of Pharmacy, graduating in 1994. He furthered his education with a Master’s Degree in Pharmaceutical Chemistry at Anadolu University’s Graduate School of Health Sciences from 1995 to 1996, where he completed his thesis. He continued at Anadolu University for his Doctoral Degree in Pharmaceutical Chemistry, which he achieved in 2004. Additionally, he possesses intermediate proficiency in English, which complements his academic background and research expertise.

Academic Titles

Prof. Dr. Ahmet Özdemir’s academic career at Anadolu University’s Faculty of Pharmacy spans several roles and achievements. He began his journey as a Research Assistant in 1997, a position he held until 2004. Following this, he advanced to the role of Research Assistant Doctor, continuing his work at the same institution from 2004 to 2005. Dr. Özdemir was then appointed as a Lecturer from 2005 to 2007, showcasing his growing expertise in the field. His contributions were recognized with a promotion to Assistant Professor Doctor, a role he embraced from 2007 to 2010. His exceptional work led to his promotion to Associate Professor Doctor, a position he held from 2010 to 2015. Since 2015, Prof. Dr. Özdemir has served as Professor Doctor, continuing to make significant contributions to the Faculty of Pharmacy and the broader academic community.

Awards

Prof. Dr. Ahmet Özdemir has received several prestigious awards for his academic and research contributions. In 2014, he was honored with the Anadolu University Article Performance Award. His outstanding achievements continued with the Anadolu University Gold Article Performance Award and the Anadolu University Platinum Article Performance Award in 2015. He maintained a high standard of excellence, receiving the Anadolu University Article Performance Award annually from 2016 to 2018. In 2019, Dr. Özdemir was recognized with the Anadolu University Academic Success Award. His consistent performance earned him the Anadolu University Article Performance Award again in 2020. Notably, in 2021, he was awarded the ISIF’21 Silver Medal for the invention titled “Targeted Novel Triazolothiadiazine Derivatives for the Treatment of Lung Cancer” at the 6th Istanbul International Inventions Fair (ISIF’21). This award was shared with Assoc. Prof. Dr. Belgin Sever, Prof. Dr. Mehlika Dilek Altintop, and Prof. Dr. Gülşen Akalın Çiftçi.

Research Focus

Prof. Dr. Ahmet Özdemir’s research is dedicated to the field of medicinal chemistry, with a keen focus on several key areas. He specializes in the synthesis of bioactive compounds, aiming to develop novel chemical entities with potential therapeutic uses, particularly targeting antifungal and antibacterial applications. His work in pharmaceutical chemistry involves investigating the physicochemical properties of these compounds, which has significant implications for drug design and efficacy. Dr. Özdemir also explores antimicrobial agents, focusing on the synthesis and evaluation of compounds designed to combat bacterial and fungal pathogens. In the realm of drug design and development, he examines structure-activity relationships to create effective and selective pharmaceutical agents. Additionally, his contributions extend to invention and innovation, where he develops novel chemical derivatives, such as triazolothiadiazine derivatives, for potential applications in treating diseases like lung cancer.

Publications

  1. “Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy”
    • Authors: Altıntop, M.D., Ertorun, İ., Akalın Çiftçi, G., Özdemir, A.
    • Year: 2024
  2. “Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents”
    • Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
    • Year: 2024
  3. “Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents”
    • Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
    • Year: 2023
  4. “Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy”
    • Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
    • Year: 2023
  5. “A new series of hydrazones as small-molecule aldose reductase inhibitors”
    • Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
    • Year: 2023
  6. “A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer”
    • Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
    • Year: 2023
  7. “Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action”
    • Authors: Altıntop, M.D., Akalın Çiftçi, G., Yılmaz Savaş, N., Alataş, Ö., Özdemir, A.
    • Year: 2023
  8. “Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency”
    • Authors: Altıntop, M.D., Temel, H.E., Özdemir, A.
    • Year: 2023
  9. “Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer”
    • Authors: Altıntop, M.D., Özdemir, A., Temel, H.E., Kaplancıklı, Z.A., Akalın Çiftçi, G.
    • Year: 2022
  10. “A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition”
    • Authors: Altıntop, M.D., Sever, B., Akalın Çiftçi, G., Alataş, Ö., Özdemir, A.
    • Year: 2022